Analyzing Visfatin Levels in Human Milk
Official title: Levels of Visfatin/NAMPT in Human Milk.VISFAMILK
Run by Paolo Manzoni · NCT06487286 · Data updated 2026-11-12
This study looks at the levels of a substance called Visfatin in breast milk from new mothers to see how it might relate to their babies' health, especially weight loss, during the first month after birth.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Paolo Manzoni Academic / other |
| Locations | 1 site (Ponderano, BI) |
| Status | Recruiting |
| Started | October 24, 2024 |
| Main results expected | April 23, 2025 |
| Study ends | April 23, 2025 |
| Registry record updated | November 14, 2024 |
| Trial ID | NCT06487286 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are healthy infants born after 37 weeks' gestation without congenital abnormalities, along with their postpartum mothers.
✕Probably not a fit
Patients who may not benefit from this study include those with conditions affecting milk production, such as hypogalactia or agalactia.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to analyze the levels of Visfatin in maternal milk samples collected from mothers during the postpartum period. Milk samples will be taken at three different time points: 48 hours, 7 days, and 30 days after birth, and Visfatin levels will be measured using an ELISA kit. Additionally, maternal plasma/serum will be evaluated to explore correlations between Visfatin levels and various biological and clinical features of both mothers and their newborns. The study focuses on understanding how these levels may relate to newborn clinical conditions, particularly weight loss.
Why it matters
Potential benefit: If successful, this study could provide insights into the role of Visfatin as a biomarker for assessing newborn health and weight management.
How similar studies have gone: While the specific focus on Visfatin levels in human milk is novel, similar studies exploring biomarkers in maternal milk have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy male and female infants born after 37 weeks' gestation who do not have conditions related to congenital abnormalities * Maternal hospitalization * Acquisition of the informed consent form signed by the patient Exclusion Criteria: * Refusal of the patient to participate in the study * Presence of hypogalactia or agalactia in the patient
Where it's running
-
Ospedale degli Infermi - ASL BI
Ponderano, Bi, Italy Recruiting
Study contacts
- Study coordinator: Paolo Manzoni, Professor
- Email: paolo.manzoni@aslbi.piemonte.it
- Phone: +39 01515156906
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cadmium Exposure in Pregnancy and Its Effect on Fetal Growth
This observational study follows pregnant people to see how cadmium exposure relates to fetal growth and birth weight.
-
Understanding Gestational Diabetes in Asian Pregnant Women
This study is trying to learn more about gestational diabetes in Asian pregnant women to see how different types of the condition affect their health and treatment options.
-
Evaluating the impact of multiple micronutrient supplementation on birth weight in Ethiopia
This study is testing whether giving pregnant women multiple vitamins instead of just iron and folic acid can help improve the birth weight of their babies in Ethiopia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.